title: [The treatment of bacterial vaginosis with Dalacin V cream].
abstract: To asses the efficiency of the 2% clindamycin phosphate creme given in 3 and 7 daily courses officially designer for the treatment of bacterial vaginosis (BV).
  
  
  METHODS
  The study includes 65 patients who have microbiological data for BV 11 of the women are pregnant (18.46%). The microbiological study includes there agent: Streptococcus agalactiae, E. colli, Gardnerella vaginalis, Peptostreptococcus species, Prevotella species, Mobiluncus species, Staphylococcus epidermidis et Enterococcus fecalis. The controls visit was assessed on the 7'] and 28'] day after the therapy.
  
  
  RESULTS
  There were successful results on the 84.3% of the patients after 7 day course but in the 3-day course the good results were showed in 73.91% of the women. After the 28"] day there were only few successful results 43%.
  
  
  CONCLUSIONS
  The clindamycin phosphate is more preferable method for the treatment of BV.
authors.forename: V
authors.initials: V
authors.lastname: POrozhanova
authors.forename: S
authors.initials: S
authors.lastname: Bozhinova
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002981:Clindamycin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000382:microbiology; D011261:Pregnancy Trimester, First; D012008:Recurrence; D013997:Time Factors; D014622:Vaginal Creams, Foams, and Jellies; D016585:Vaginosis, Bacterial / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D014622:Vaginal Creams, Foams, and Jellies; D002981:Clindamycin; C007084:clindamycin phosphate